Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS · Delayed Price · Currency is USD
14.80
0.00 (0.00%)
At close: Mar 7, 2025

TEVJF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
18,88325,00611,70310,1298,83510,576
Upgrade
Market Cap Growth
113.68%113.68%15.54%14.65%-16.46%-1.18%
Upgrade
Enterprise Value
34,11441,28130,33430,27531,94535,841
Upgrade
Last Close Price
14.8018.508.628.948.659.40
Upgrade
PE Ratio
----21.19-
Upgrade
PS Ratio
1.511.510.740.680.560.63
Upgrade
PB Ratio
4.374.371.441.180.790.96
Upgrade
P/FCF Ratio
33.3933.3913.909.7237.4416.58
Upgrade
P/OCF Ratio
20.0520.058.556.3711.078.70
Upgrade
EV/Sales Ratio
2.062.501.912.032.012.15
Upgrade
EV/EBITDA Ratio
7.469.327.007.637.257.77
Upgrade
EV/EBIT Ratio
10.1112.249.5411.3710.3811.73
Upgrade
EV/FCF Ratio
45.5555.1236.0329.05135.3656.18
Upgrade
Debt / Equity Ratio
3.183.182.492.522.102.40
Upgrade
Debt / EBITDA Ratio
3.983.984.535.265.195.57
Upgrade
Debt / FCF Ratio
24.2824.2824.0820.8099.9741.59
Upgrade
Asset Turnover
0.400.400.360.330.320.31
Upgrade
Inventory Turnover
2.412.412.092.082.022.02
Upgrade
Quick Ratio
0.500.500.540.570.610.51
Upgrade
Current Ratio
0.980.981.021.051.140.99
Upgrade
Return on Equity (ROE)
-28.30%-28.30%-7.35%-25.19%4.09%-31.38%
Upgrade
Return on Assets (ROA)
5.09%5.09%4.54%3.63%3.91%3.53%
Upgrade
Return on Capital (ROIC)
8.06%8.06%6.77%5.11%5.31%4.77%
Upgrade
Return on Capital Employed (ROCE)
12.71%12.71%10.18%8.18%8.40%8.15%
Upgrade
Earnings Yield
-8.68%-6.55%-4.78%-24.15%4.72%-37.73%
Upgrade
FCF Yield
3.97%3.00%7.19%10.29%2.67%6.03%
Upgrade
Buyback Yield / Dilution
-1.07%-1.07%-0.81%-0.27%-1.10%-0.37%
Upgrade
Total Shareholder Return
-1.07%-1.07%-0.81%-0.27%-1.10%-0.37%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.